Shanghai, China · Founded 2020 · Privately Held (backing)
Developer of new drugs designed for tumors, neurodegenerative diseases, autoimmune diseases and other diseases. Yuyao Biotechnology is based in Shanghai, China and was founded in 2020. It has raised $90.3 million.
Last price · $/share
—
Implied valuation
—
Total raised
$90.3M
Last round
—
Cap table — not yet on record
Yuyao Biotechnology's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Yuyao Biotechnology with a free account
·Watch Yuyao Biotechnology: the Monday email on marks, rounds and moves
